Cystine knot growth factor mutants

Details for Australian Patent Application No. 2005201529 (hide)

Owner University of Maryland, Baltimore

Inventors Szkudlinski, Mariusz W.; Weintraub, Bruce D

Agent Fisher Adams Kelly

Pub. Number AU-A-2005201529

Parent 778998

Filing date 12 April 2005

Wipo publication date 12 May 2005

International Classifications

C12N 015/16 Mutation or genetic engineering - Hormones

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

A61K 038/24 Medicinal preparations containing peptides - Follicle-stimulating hormone (FSH)

C07K 014/575 Peptides having more than 20 amino acids

C07K 014/51 Peptides having more than 20 amino acids

C07K 014/47 Peptides having more than 20 amino acids

C07K 014/495 Peptides having more than 20 amino acids

C07K 014/475 Peptides having more than 20 amino acids

C07K 014/49 Peptides having more than 20 amino acids

C07K 014/59 Peptides having more than 20 amino acids

Event Publications

28 April 2005 Complete Application Filed

12 May 2005 Application Open to Public Inspection

  Published as AU-A-2005201529

15 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005201530-A packaging

2005201528-A retractable syringe